Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in …

S Meyer-Moock, YS Feng, M Maeurer, FW Dippel… - BMC neurology, 2014 - Springer
Background There are a number of instruments that describe severity and progression of
multiple sclerosis and they are increasingly used as endpoints to assess the effectiveness of …

A comprehensive review of the paced auditory serial addition test (PASAT)

TN Tombaugh - Archives of clinical neuropsychology, 2006 - academic.oup.com
Abstract The Paced Auditory Serial Addition Test (PASAT)[Gronwall, D., & Sampson,
H.(1974). The psychological effects of concussion. Auckland, New Zealand: Auckland …

Variability and standardization of quantitative imaging: monoparametric to multiparametric quantification, radiomics, and artificial intelligence

A Hagiwara, S Fujita, Y Ohno, S Aoki - Investigative radiology, 2020 - journals.lww.com
Radiological images have been assessed qualitatively in most clinical settings by the expert
eyes of radiologists and other clinicians. On the other hand, quantification of radiological …

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

AD Goodman, TR Brown, LB Krupp, RT Schapiro… - The Lancet, 2009 - thelancet.com
Background Clinical studies suggested that fampridine (4-aminopyridine) improves motor
function in people with multiple sclerosis. This phase III study assessed efficacy and safety of …

Benefit of interferon β-1a on MSFC progression in secondary progressive MS

JA Cohen, GR Cutter, JS Fischer, AD Goodman… - Neurology, 2002 - AAN Enterprises
Background: Interferon β-1a (IFNβ-1a, Avonex) is efficacious in relapsing forms of MS.
Studies of other IFNβ preparations in secondary progressive MS (SPMS) yielded conflicting …

The significant change for the Timed 25-foot Walk in the multiple sclerosis functional composite

M Kaufman, D Moyer, J Norton - Multiple Sclerosis Journal, 2000 - journals.sagepub.com
The Timed 25-Foot Walk is under evaluation as a clinical tool to follow patients with MS.
Several approaches have been taken to define a clinically significant change in this …

Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients

N Yozbatıran, F Baskurt, Z Baskurt, S Ozakbas… - Journal of the …, 2006 - Elsevier
OBJECTIVES: The aim of this study was to assess the motor function of upper extremity and
its relation with fatigue, cognitive function and quality of life in Multiple Sclerosis (MS) …

The multiple sclerosis functional composite: a new clinical outcome measure for multiple sclerosis trials

RA Rudick, G Cutter, S Reingold - Multiple Sclerosis Journal, 2002 - journals.sagepub.com
With the advent and widespread use of partially effective disease modifying drug therapies
for multiple sclerosis (MS), future clinical trials will undoubtedly test experimental …

Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MS

J Hobart, AR Blight, A Goodman, F Lynn, N Putzki - Neurology, 2013 - AAN Enterprises
Objective: In this study, we used data from clinical trials of dalfampridine (fampridine outside
the United States) to re-examine the clinical meaningfulness of Timed 25-Foot Walk …

Responsiveness of different rating instruments in spinocerebellar ataxia patients

T Schmitz-Hubsch, R Fimmers, M Rakowicz, R Rola… - Neurology, 2010 - AAN Enterprises
Objective: To determine the longitudinal metric properties of recently developed clinical
assessment tools in spinocerebellar ataxia (SCA). Methods: A subset of 171 patients from …